This common gastrointestinal side effect occurs in approximately 8-30% of patients taking semaglutide (Ozempic, Wegovy, or Rybelsus) and is most pronounced during initial treatment and dose escalations
Future studies should delve deeper into these mechanisms, develop more effective diagnostic methods, and create personalized treatment plans to improve patient outcomes
Three replicates were used for each concentration (100 larvae per replicate)
These drugs acknowledge that, in some ways, their large body may be the result of biological factors
doi:10.1002/(SICI)1097-0134(19990601)35:4 3.0.CO;2-2
Disclaimer: Please be aware that results and benefits may vary from patient to patient taking into consideration factors such as age, lifestyle and medical history